Showing results (1671-1680 of 2,968) with videos related to
Sort By:
Pageof 297
Neuro Endocrinology Letters|May 4, 2001
Effect of aproteic diet and fasting on insulin, pancreatic noradrenaline and luteinizing hormone. Changes after 24-hour refeedingOsvaldo J. S. Ponzo, Miguel A. Cresta, Dora Rondina, et al.Neuro Endocrinology Letters|May 4, 2001
Melatonin protects against oxidative stress induced by the kidney carcinogen KBrO(3)Gamal H. El-SokkaryNeuro Endocrinology Letters|May 4, 2001
Gestational progesterone suppresses embryotoxic action of the complement system to chick embryoM Zeman, P NovákováNeuro Endocrinology Letters|May 4, 2001
Focal ischemia in the cerebral cortex has an effect on the neurohypophysis. I. Ultrastructural changes in capillary vessels of the neurohypophysis after focal ischemia of the cerebral cortexM Frontczak-BaniewiczNeuro Endocrinology Letters|May 4, 2001
Melatonin production in patients with duodenal ulcerN Malinovskaya, F I Komarov, S I Rapoport, et al.Neuro Endocrinology Letters|June 25, 2002
Cellular localization of a chromogranin B-like derived peptides in leechesMichel Salzet, Martine Verger-BocquetNeuro Endocrinology Letters|June 25, 2002
Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodesMiguel N Hissa, José Artur C D'Almeida, Fernanda Cremasco, et al.Neuro Endocrinology Letters|June 25, 2002
Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in ratsAndrea Tamás, Dóra Reglõdi, Zalán Szántó, et al.Neuro Endocrinology Letters|June 25, 2002
A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alonePaolo Lissoni, Fabio Malugani, Veronica Bordin, et al.Pageof 297